Res-Q was developed by ThermoGenesis Corp. to compliment its MXP system.
Celling is also establishing Institutes of Regenerative Medicine to further research and develop therapies for adult stem cells.
Read Celling Technologies’ release on Res-Q.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
